Filing Details

Accession Number:
0001666071-21-000013
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-02-24 16:14:09
Reporting Period:
2021-02-23
Accepted Time:
2021-02-24 16:14:09
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1666071 Cardlytics Inc. CDLX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1617486 D. Scott Grimes C/o Cardlytics, Inc.
675 Ponce De Leon Avenue Ne, Suite 6000
Atlanta GA 30308
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-02-23 300 $134.33 240,608 No 4 S Direct
Common Stock Disposition 2021-02-23 598 $135.74 240,010 No 4 S Direct
Common Stock Disposition 2021-02-23 300 $137.33 239,710 No 4 S Direct
Common Stock Disposition 2021-02-23 402 $139.21 239,308 No 4 S Direct
Common Stock Disposition 2021-02-23 200 $139.66 239,108 No 4 S Direct
Common Stock Disposition 2021-02-23 200 $141.62 238,908 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 93,112 Indirect See Footnote
Footnotes
  1. These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 12, 2020.
  2. The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $134.16 to $134.47, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4), (5), (6) and (7) to this Form 4.
  3. The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $135.35 to $136.08, inclusive.
  4. The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $136.70 to $137.65, inclusive.
  5. The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $138.47 to $139.44, inclusive.
  6. The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $139.49 to $139.83, inclusive.
  7. The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $141.45 to $141.79, inclusive.
  8. The reportable securities are held by the 2013 Scott Grimes GRAT UAD.